NCT03915327View on ClinicalTrials.gov

Short-term Intravenous Iron Isomaltose Anhydride for IDA

NANot yet recruitingINTERVENTIONAL
Enrollment

1,600

Participants

Timeline

Start Date

July 5, 2024

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2029

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Intravenous iron isomaltose anhydride

Enrolled subjects would receive intravenous iron isomaltose anhydride within 24 hours of the subject's inclusion.

All Listed Sponsors
lead

West China Hospital

OTHER

NCT03915327 - Short-term Intravenous Iron Isomaltose Anhydride for IDA | Biotech Hunter | Biotech Hunter